超声背散射定量肝脏脂肪:AIUM-RSNA QIBA 脉冲回波定量超声倡议
本文综述了超声背散射参数(包括肝肾指数和背散射系数)在无创评估非酒精性脂肪性肝病(NAFLD)肝脂肪变中的科学原理与临床证据。AIUM与RSNA QIBA正在推动标准化超声采集协议和数据分析方法,以提高背散射系数在肝脏脂肪评估中的诊断性能,并提出了减少技术和生物学变量混杂效应的数据收集建议。
要点
- 背散射系数和肝肾指数是定量评估肝脂肪变的超声参数,有望替代活检和MRI。
- B型超声回声强度的视觉评估受观察者间变异影响,定量背散射参数可减少主观性。
- 标准化采集协议和数据分析方法对提高背散射系数诊断性能至关重要。
英文原文(摘要)· 点击展开
Nonalcoholic fatty liver disease (NAFLD) is believed to affect one-third of American adults. Noninvasive methods that enable detection and monitoring of NAFLD have the potential for great public health benefits. Because of its low cost, portability, and noninvasiveness, US is an attractive alternative to both biopsy and MRI in the assessment of liver steatosis. NAFLD is qualitatively associated with enhanced B-mode US echogenicity, but visual measures of B-mode echogenicity are negatively affected by interobserver variability. Alternatively, quantitative backscatter parameters, including the hepatorenal index and backscatter coefficient, are being investigated with the goal of improving US-based characterization of NAFLD. The American Institute of Ultrasound in Medicine and Radiological Society of North America Quantitative Imaging Biomarkers Alliance are working to standardize US acquisition protocols and data analysis methods to improve the diagnostic performance of the backscatter coefficient in liver fat assessment. This review article explains the science and clinical evidence underlying backscatter for liver fat assessment. Recommendations for data collection are discussed, with the aim of minimizing potential confounding effects associated with technical and biologic variables.
引用
- Wear, Han, Rubin, et al. US Backscatter for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative. Radiology. 2022. PMID: 36255312. doi:10.1148/radiol.220606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。